BNP-guided therapy for chronic heart failure: Anything more than just an attractive concept?

摘要

The measurement of plasma natriuretic peptides (NPs) is well established in the diagnostic work-up of patients with suspected heart failure (HF), and is known to be a powerful prognostic tool, but the evidence that serial measurement can help improve the outcome of patients with HF has been elusive. As yet, no international guideline supports such use.